Potential lower prices risk not only bringing down revenue from medicines already on the market, but also hurting the long-term innovation that is crucial for the industry. The pharmaceutical sector ...

Global Generic Pharmaceuticals Market Poised for Robust Growth: Projected to Reach $916.2 Billion by 2033 with Strong Gains in Asia-Pacific and Emerg ...

In a recent BioSpace LinkedIn poll, nearly half of respondents predicted the job market won’t turn around until 2027 or later ...

The table below is a review of notable updates that occurred in April 2025 for investigational products in development.

NewLimit, an anti-aging biotech startup backed by Coinbase CEO Brian Armstrong, raised a $130 million Series B round.

Kroger, Albertsons and others allege an unlawful monopoly in one legal case and aim to recover overcharges for a drug in ...

Teva Pharmaceutical Industries (NYSE:TEVA) recently made headlines by agreeing to a $2.25 million settlement in a ...

The FDA approved ustekinumab-aekn (Selarsdi) injection as an interchangeable biosimilar to Stelara for the treatment of Crohn ...

CEO Richard Daly highlighted Catalyst's strong start to 2025 with $141.4 million in total net revenues, reflecting a 43.6% year-over-year growth. Key contributors included FIRDAPSE, AGAMREE, and ...

Health workers from different parts of Ghana have promised the Chief Executive of Peace and Love Hospital, Dr. Beatrice Wiafe ...

Royalty Receipts was $788 million in the first quarter of 2025, an increase of 12% compared to $705 million in the first quarter of 2024. The increase was primarily driven by strong growth from the ...

With the publication of its 2024 results, Teva provided guidance that disappointed investors and the stock lost about 25% of ...